DNDi’s FACT Project: A New Kind of Partnership to Deliver New Products.

From:
Department for International Development
Published
1 January 2008
Document Type:
Conference Paper
Theme:
Health
Authors:
Kiechel, J.R.

Abstract

This presentation describes the Fixed-Dose ACT Project for Malaria, which led to the development of the new antimalarial formulations ASAQ (artesunate-amodiaquine) and ASMQ (artesunate-mefloquine): the reasons why these formulations were needed, the partnership of public and private sector organizations that were involved in their development, the cost and sources of funding, and (briefly) the outlook for implementation of the new therapies.

Citation

Kiechel, J.R. DNDi’s FACT Project: A New Kind of Partnership to Deliver New Products. (2008)

DNDi’s FACT Project: A New Kind of Partnership to Deliver New Products.

Updates to this page

Published 1 January 2008
Contents